vs
Canterbury Park Holding Corp（CPHC）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Canterbury Park Holding Corp的季度营收约是Protalix BioTherapeutics, Inc.的1.4倍（$12.4M vs $9.1M），Canterbury Park Holding Corp净利率更高（-3.1% vs -60.3%，领先57.2%），Canterbury Park Holding Corp同比增速更快（3.9% vs -49.9%），Protalix BioTherapeutics, Inc.自由现金流更多（$1.6M vs $-611.3K），过去两年Canterbury Park Holding Corp的营收复合增速更高（-6.0% vs -6.7%）
坎特伯雷公园控股公司在美国明尼苏达州沙科皮运营赛马场，在场地内为纯种马和夸特马现场赛马提供同赌投注服务，同时也为外州赛马场同步转播的赛事提供同赌投注服务。此外，该公司还旗下还运营全天候开放的坎特伯雷公园纸牌赌场，业务受明尼苏达州赛马委员会监管。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
CPHC vs PLX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $12.4M | $9.1M |
| 净利润 | $-390.1K | $-5.5M |
| 毛利率 | — | 49.4% |
| 营业利润率 | 2.6% | -51.1% |
| 净利率 | -3.1% | -60.3% |
| 营收同比 | 3.9% | -49.9% |
| 净利润同比 | 68.7% | -184.8% |
| 每股收益（稀释后） | $-0.08 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $12.4M | $9.1M | ||
| Q3 25 | $18.3M | $17.9M | ||
| Q2 25 | $15.7M | $15.7M | ||
| Q1 25 | $13.1M | $10.1M | ||
| Q4 24 | $12.0M | $18.2M | ||
| Q3 24 | $19.3M | $18.0M | ||
| Q2 24 | $16.2M | $13.5M | ||
| Q1 24 | $14.1M | — |
| Q4 25 | $-390.1K | $-5.5M | ||
| Q3 25 | $487.3K | $2.4M | ||
| Q2 25 | $-327.4K | $164.0K | ||
| Q1 25 | $-299.2K | $-3.6M | ||
| Q4 24 | $-1.2M | $6.5M | ||
| Q3 24 | $2.0M | $3.2M | ||
| Q2 24 | $338.3K | $-2.2M | ||
| Q1 24 | $998.2K | — |
| Q4 25 | — | 49.4% | ||
| Q3 25 | — | 53.4% | ||
| Q2 25 | — | 62.5% | ||
| Q1 25 | — | 19.1% | ||
| Q4 24 | — | 78.7% | ||
| Q3 24 | — | 53.4% | ||
| Q2 24 | — | 29.8% | ||
| Q1 24 | — | — |
| Q4 25 | 2.6% | -51.1% | ||
| Q3 25 | 5.7% | 11.9% | ||
| Q2 25 | 2.8% | 7.5% | ||
| Q1 25 | 4.9% | -41.0% | ||
| Q4 24 | -0.8% | 39.6% | ||
| Q3 24 | 18.9% | 22.2% | ||
| Q2 24 | 6.9% | -18.0% | ||
| Q1 24 | 12.5% | — |
| Q4 25 | -3.1% | -60.3% | ||
| Q3 25 | 2.7% | 13.2% | ||
| Q2 25 | -2.1% | 1.0% | ||
| Q1 25 | -2.3% | -35.8% | ||
| Q4 24 | -10.4% | 35.6% | ||
| Q3 24 | 10.5% | 18.0% | ||
| Q2 24 | 2.1% | -16.4% | ||
| Q1 24 | 7.1% | — |
| Q4 25 | $-0.08 | $-0.06 | ||
| Q3 25 | $0.10 | $0.03 | ||
| Q2 25 | $-0.06 | $0.00 | ||
| Q1 25 | $-0.06 | $-0.05 | ||
| Q4 24 | $-0.25 | $0.10 | ||
| Q3 24 | $0.40 | $0.03 | ||
| Q2 24 | $0.07 | $-0.03 | ||
| Q1 24 | $0.20 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $17.1M | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $83.9M | $48.2M |
| 总资产 | $112.6M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $17.1M | $14.7M | ||
| Q3 25 | $16.7M | $13.6M | ||
| Q2 25 | $16.9M | $17.9M | ||
| Q1 25 | $15.4M | $19.5M | ||
| Q4 24 | $15.1M | $19.8M | ||
| Q3 24 | $21.7M | $27.4M | ||
| Q2 24 | $23.8M | $23.4M | ||
| Q1 24 | $25.2M | — |
| Q4 25 | $83.9M | $48.2M | ||
| Q3 25 | $84.1M | $52.9M | ||
| Q2 25 | $83.6M | $49.9M | ||
| Q1 25 | $83.7M | $45.2M | ||
| Q4 24 | $84.1M | $43.2M | ||
| Q3 24 | $85.2M | $32.4M | ||
| Q2 24 | $83.2M | $28.6M | ||
| Q1 24 | $82.7M | — |
| Q4 25 | $112.6M | $82.3M | ||
| Q3 25 | $114.4M | $82.3M | ||
| Q2 25 | $114.9M | $78.5M | ||
| Q1 25 | $112.4M | $73.9M | ||
| Q4 24 | $109.9M | $73.4M | ||
| Q3 24 | $114.2M | $61.6M | ||
| Q2 24 | $111.4M | $91.5M | ||
| Q1 24 | $105.6M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-103.4K | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $-611.3K | $1.6M |
| 自由现金流率自由现金流/营收 | -4.9% | 17.8% |
| 资本支出强度资本支出/营收 | 4.1% | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $4.7M | $-13.6M |
8季度趋势，按日历期对齐
| Q4 25 | $-103.4K | $2.0M | ||
| Q3 25 | $1.2M | $-3.7M | ||
| Q2 25 | $4.4M | $-5.2M | ||
| Q1 25 | $3.4M | $-5.1M | ||
| Q4 24 | $-2.8M | $4.0M | ||
| Q3 24 | $2.3M | $4.1M | ||
| Q2 24 | $5.4M | $-3.6M | ||
| Q1 24 | $1.6M | — |
| Q4 25 | $-611.3K | $1.6M | ||
| Q3 25 | $-395.3K | $-4.2M | ||
| Q2 25 | $3.2M | $-5.7M | ||
| Q1 25 | $2.5M | $-5.4M | ||
| Q4 24 | $-6.7M | $3.6M | ||
| Q3 24 | $-25 | $4.0M | ||
| Q2 24 | $1.8M | $-3.8M | ||
| Q1 24 | $-601.0K | — |
| Q4 25 | -4.9% | 17.8% | ||
| Q3 25 | -2.2% | -23.7% | ||
| Q2 25 | 20.5% | -36.2% | ||
| Q1 25 | 19.1% | -53.0% | ||
| Q4 24 | -55.9% | 19.6% | ||
| Q3 24 | -0.0% | 22.4% | ||
| Q2 24 | 11.1% | -28.1% | ||
| Q1 24 | -4.3% | — |
| Q4 25 | 4.1% | 4.4% | ||
| Q3 25 | 9.0% | 2.8% | ||
| Q2 25 | 7.5% | 2.8% | ||
| Q1 25 | 6.5% | 3.0% | ||
| Q4 24 | 32.6% | 2.3% | ||
| Q3 24 | 11.8% | 0.5% | ||
| Q2 24 | 22.2% | 1.3% | ||
| Q1 24 | 15.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | 2.56× | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | 1.12× | 1.27× | ||
| Q2 24 | 15.95× | — | ||
| Q1 24 | 1.62× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CPHC
| Casino | $9.5M | 76% |
| Other | $1.9M | 15% |
| Food And Beverage | $1.0M | 8% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
